Brief: Lineage Cell Therapeutics Provides Update On Renevia Commercialization Plans
25/09/2019 13:42
Sept 25 (Reuters) - Lineage Cell Therapeutics Inc LCTX.A :
* LINEAGE CELL THERAPEUTICS PROVIDES UPDATE ON RENEVIA
COMMERCIALIZATION PLANS
* LINEAGE CELL THERAPEUTICS INC - SERCADER LTD. ENGAGED TO
IDENTIFY EUROPEAN COMMERCIAL PARTNER
Source text for Eikon: ID:nBw2XkR6ha
Further company coverage: LCTX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million